Coeptis Therapeutics' SNAP-CAR Technology Platform for Programmable Antigen Targeting Featured in Peer-Reviewed Article in Nature Communications

/PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy...

Related Keywords

,Jon Nugent ,Dave Mehalick ,Jason Lohmueller ,Karolinska Institutet ,David Schemelia ,Coeptis Pharmaceuticals Inc ,University Of Pittsburgh ,Drug Administration ,Prnewswire Coeptis Therapeutics Holdings Inc ,Nature Communications ,Coeptis Therapeutics Inc ,Coeptis Therapeutics Holdings Inc ,Securities Exchange ,Holdings Inc ,Division Of Surgical Oncology Research ,Nasdaq ,Exchange Commission ,Therapeutics Holdings ,Assistant Professor ,Surgical Oncology Research ,Coeptis Therapeutics ,Coeptis Therapeutics Holdings ,Coeptis Pharmaceuticals ,Deverra Therapeutics ,Securities Act ,Securities Exchange Act ,Nasdaq Global Market ,